ZNF224 and plasma cell myeloma: Among them, ZNF224 plays a crucial role in the NF-kB pathway activation in bladder cancer and myeloma cells (Harada et al., 2010; Sun et al., 2014), thus exerting an oncogenic function through the activation of anti-apoptotic and pro-survival signals.